+1 888-880-9539Email Us Here
Salugen Acquired by Swiss Investment Group Sherbrooke Equity (FRA: S59) and Becomes Salugen AG
Early stage nutrigenomics company, Salugen, is acquired by Swiss Investment Group
Salugen Acquired by Swiss Investment Group Sherbrooke Equity (FRA: S59) and Becomes Salugen AG
Early stage nutrigenomics company, Salugen, is acquired by Swiss Investment Group